Literature DB >> 31846919

Mastoid Obliteration with Synthetic Materials: A Review of the Literature.

Charalampos Skoulakis1, Petros Koltsidopoulos1, Arunachalam Iyer2, Georgios Kontorinis3.   

Abstract

Canal wall down mastoidectomy is a surgical technique used for the eradication of middle ear disease. The remaining large mastoid bowl is associated with a number of issues; one of the main techniques that have been developed in order to avoid such problems is the obliteration of the mastoid cavity. The materials used for this reason are either biological or synthetic. The purpose of this survey is to review the published literature related to the therapeutic value of mastoid obliteration with synthetic materials. We searched Web of Science, PubMed, and MEDLINE from 2008 to 2018 using the criteria mastoid obliteration, canal wall down mastoidectomy, chronic otitis media, and cholesteatoma. The search focused on papers concerning the mastoid obliteration with synthetic material, as we focused on looking for outcomes and reported complications. Out of a total of 244 citations, 15 articles were identified, where patients underwent mastoid obliteration with synthetic materials. Most authors used bioactive glass as a filler material. Mastoid obliteration resulted in a decrease in the complications associated with the open mastoid cavity. On the basis of the available limited literature, it seems that mastoid obliteration with synthetic materials is a valuable and safe surgical technique for patients who undergo canal wall down mastoidectomy. The bioactive glass appears to be the most reliable synthetic material.

Entities:  

Mesh:

Year:  2019        PMID: 31846919      PMCID: PMC6937173          DOI: 10.5152/iao.2019.7038

Source DB:  PubMed          Journal:  J Int Adv Otol        ISSN: 1308-7649            Impact factor:   1.017


  25 in total

1.  Mastoidectomy cavity obliteration with bioactive glass: a pilot study.

Authors:  Juha Tapio Silvola
Journal:  Otolaryngol Head Neck Surg       Date:  2012-02-27       Impact factor: 3.497

2.  Antibacterial effect of bioactive glasses on clinically important anaerobic bacteria in vitro.

Authors:  Outi Leppäranta; Minna Vaahtio; Timo Peltola; Di Zhang; Leena Hupa; Mikko Hupa; Heimo Ylänen; Jukka I Salonen; Matti K Viljanen; Erkki Eerola
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

3.  Bactericidal effects of bioactive glasses on clinically important aerobic bacteria.

Authors:  Eveliina Munukka; Outi Leppäranta; Mika Korkeamäki; Minna Vaahtio; Timo Peltola; Di Zhang; Leena Hupa; Heimo Ylänen; Jukka I Salonen; Matti K Viljanen; Erkki Eerola
Journal:  J Mater Sci Mater Med       Date:  2007-06-14       Impact factor: 3.896

Review 4.  The management of pediatric cholesteatoma.

Authors:  Jack A Shohet; Andrew L de Jong
Journal:  Otolaryngol Clin North Am       Date:  2002-08       Impact factor: 3.346

5.  Bioactive glass S53P4 in frontal sinus obliteration: a long-term clinical experience.

Authors:  Matti Peltola; Kalle Aitasalo; Jouko Suonpää; Matti Varpula; Antti Yli-Urpo
Journal:  Head Neck       Date:  2006-09       Impact factor: 3.147

6.  Ceravital reconstruction of canal wall down mastoidectomy: long-term results.

Authors:  Charles C Della Santina; Su Cherl Lee
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2006-06

7.  Bioglass reconstruction of posterior meatal wall after canal wall down mastoidectomy.

Authors:  Samir Sorour Sorour; Nasser Nagieb Mohamed; Magdy M Abdel Fattah; Mohammad El-Sayed Abd Elbary; Mohammad Waheed El-Anwar
Journal:  Am J Otolaryngol       Date:  2018-03-06       Impact factor: 1.808

8.  Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage.

Authors:  Jussi Sarin; Reidar Grénman; Kalle Aitasalo; Jaakko Pulkkinen
Journal:  Ann Otol Rhinol Laryngol       Date:  2012-09       Impact factor: 1.547

9.  Mastoid obliteration with hydroxyapatite cement: the Ipswich experience.

Authors:  S Mahendran; M W Yung
Journal:  Otol Neurotol       Date:  2004-01       Impact factor: 2.311

10.  Platelet-Rich Plasma in Reconstruction of Posterior Meatal Wall after Canal Wall Down Mastoidectomy.

Authors:  Mohammad El-Sayed Abd Elbary; Wail Fayez Nasr; Samir Sorour Sorour
Journal:  Int Arch Otorhinolaryngol       Date:  2017-05-17
View more
  6 in total

1.  Mastoid obliteration with hydroxyapatite vs. bone pâté in mastoidectomy surgery performed on patients with cholesteatoma and chronic suppurative otitis media: a retrospective analysis.

Authors:  Jantine J Lindeboom; P M W van Kempen; J Buwalda; B O Westerlaken; D A van Zuijlen; S J H Bom; F B van der Beek
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-29       Impact factor: 3.236

2.  Mid-term outcomes of mastoid obliteration with biological hydroxyapatite versus bioglass: a radiological and clinical study.

Authors:  Sonia Sahli-Vivicorsi; Zarrin Alavi; William Bran; Romain Cadieu; Philippe Meriot; Jean-Christophe Leclere; Rémi Marianowski
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-17       Impact factor: 3.236

3.  Antibiotics in mastoid and epitympanic obliteration with S53P4 bioactive glass: A retrospective study.

Authors:  Lauranne Alciato; Daniele Bernardeschi; Valérie Pourcher; Naira Mkrtchyan; Frédéric Tankéré; Olivier Sterkers; Ghizlène Lahlou
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-09-14

4.  Implantation of the Bonebridge BCI 602 after Mastoid Obliteration with S53P4 Bioactive Glass: A Safe Method of Treating Difficult Anatomical Conditions-Preliminary Results.

Authors:  Bartłomiej Król; Katarzyna Beata Cywka; Magdalena Beata Skarżyńska; Piotr Henryk Skarżyński
Journal:  Life (Basel)       Date:  2021-04-22

5.  Long-term follow-up of applying autologous bone grafts for reconstructing tympanomastoid defects in functional cholesteatoma surgery.

Authors:  Wei-Che Lan; Ching-Yuan Wang; Ming-Hsui Tsai; Chia-Der Lin
Journal:  PeerJ       Date:  2021-11-23       Impact factor: 2.984

6.  A Multicenter Retrospective Case Review of Outcomes and Complications of S53P4 Bioactive Glass.

Authors:  Colin G Leonard; Sinead McNally; Mark Adams; Susie Hampton; Edward McNaboe; C Ekambar E Reddy; Neil A Bailie
Journal:  J Int Adv Otol       Date:  2021-05       Impact factor: 1.316

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.